Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation

This study investigates the association between immunotherapy and symptomatic radiation necrosis in patients with melanoma, non–small-cell lung cancer, or renal cell carcinoma and newly diagnosed brain metastases treated with stereotactic radiation therapy.

• Publication year

  2018

• Venue

  JAMA Oncology

• Publication date

  2018-08-01

• Fields of study

  Medicine, Physics

• Identifiers
  DOI 10.1001/jamaoncol.2017.3993PMID 29327059PMCID PMC5885198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204.

  2017cited by this paper
• Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.

  2016cited by this paper
• A randomized phase 2 study of nivolumab and nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases: The Anti-PD1 Brain Collaboration (ABC Study).

  2016cited by this paper
• Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids

  2015cited by this paper
• Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.

  2012cited by this paper
• Cerebral Radiation Necrosis

  2003cited by this paper

• Symptomatic radiation necrosis after concurrent targeted therapy and stereotactic radiosurgery for brain metastases: a bicentric retrospective analysis

  2026cites this paper
• Outcomes of patients with melanoma brain metastases treated with ipilimumab and nivolumab with or without upfront comprehensive stereotactic radiosurgery

  2026cites this paper
• Irradiated tumor volume as a predictor of local recurrence and radionecrosis in lung cancer with brain metastases treated with stereotactic radiosurgery

  2026cites this paper
• Stereotactic Radiosurgery Dose Reduction for Patients With Brain Metastases From Non-Small Cell Lung Primary on Immunotherapy or Targeted Therapy.

  2026cites this paper
• Life-Threatening Radiation Necrosis After Complete Response to Pembrolizumab in a Patient With a Metastatic Silent PIT1 Pituitary Neuroendocrine Tumor (PitNET).

  2026cites this paper
• First-Line Camrelizumab versus Placebo Plus Chemotherapy with or without Radiotherapy for Brain Metastases in Non-Small-Cell Lung Cancer: The CTONG 2003 Randomized Placebo-Controlled Trial.

  2025cites this paper
• Integrating CNS-active therapy with stereotactic radiotherapy for brain metastases: comparative outcomes of PULSAR and FSRT

  2025cites this paper
• Predicting Radionecrosis After Stereotactic Radiation Therapy for Solitary Brain Metastases: External Validation of a Univariable Model and Development of a Multivariable Model

  2025influential citation
• Local recurrence and radionecrosis after single-isocenter multiple targets stereotactic radiotherapy for brain metastases

  2025cites this paper
• The evolving landscape of brain metastasis: volume II.

  2025cites this paper
• Multistage Biobarrier-Adaptive Peptide Radiosensitizer with Low-Dose X-ray Augments Glioblastoma Radiotherapy via Destabilizing Lysosomal Homeostasis.

  2025cites this paper
• Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study

  2025cites this paper
• Management outcomes for biopsy-proven radiation necrosis in patients with brain metastases in the era of immune-checkpoint blockade

  2025cites this paper
• Tailored radiotherapy for brain metastases improves precision and outcomes

  2025influential citation
• Combined stereotactic radiotherapy and immunotherapy improves survival in driver-gene-negative NSCLC patients with brain oligo-metastases: a multicenter real-world study

  2025cites this paper
• Opportunities and challenges for non-small cell lung cancer brain metastases in the immunotherapy era.

  2025cites this paper
• Immunotherapy may promote the occurrence of radiation-induced brain injury in NSCLC patients with brain metastases undergoing radiotherapy: a retrospective propensity score-matching and inverse probability of treatment weighting study

  2025cites this paper
• Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases

  2025influential citation
• Focusing attention on brain metastasis: Hot issues.

  2025cites this paper
• Impact of stereotactic radiosurgery timing relative to immune checkpoint blockade administration on brain metastasis disease and radionecrosis outcomes

  2025cites this paper
• Postoperative Stereotactic Radiosurgery for Resected Brain Metastases: Targeting of the Surgical Tract.

  2025cites this paper
• Commentary: Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines Update for the Role of Emerging Therapies in the Management of Patients With Metastatic Brain Tumors.

  2025cites this paper
• Efficacy of Radiotherapy for Oligometastatic Lung Cancer and Irradiation Methods Based on Metastatic Site

  2025cites this paper
• Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care

  2025cites this paper
• Seizure risk factors and management approaches in patients with brain metastases.

  2025cites this paper
• Navigating the Complexities of Brain Metastases Management.

  2024cites this paper
• Symptomatic brain metastases in melanoma

  2024cites this paper
• Radiation and Melanoma: Where Are We Now?

  2024cites this paper
• Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer.

  2024cites this paper
• Local and Systemic Management Options for Melanoma Brain Metastases.

  2024cites this paper
• The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases.

  2024cites this paper
• Stereotactic Radiosurgery and Stereotactic Fractionated Radiotherapy in the Management of Brain Metastases

  2024cites this paper
• Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review.

  2024cites this paper
• Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy

  2024cites this paper
• External border zone may be correlated with radiation necrosis after radiosurgery in metastatic brain tumor.

  2024cites this paper
• The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases.

  2024cites this paper
• Advances in the Management of Lung Cancer Brain Metastases

  2024cites this paper
• Exploratory Evaluation of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) with CNS-Active Drugs in Brain Metastases Treatment.

  2024cites this paper
• Efficacy and safety of combining anti-angiogenic therapy, radiotherapy, and PD-1 inhibitors in patients with driver gene-negative non-small cell lung cancer brain metastases: a retrospective study

  2024cites this paper
• Local control and toxicity after stereotactic radiotherapy in brain metastases patients and the impact of novel systemic treatments.

  2024cites this paper
• Precision radiotherapy with molecular-profiling of CNS tumours

  2024cites this paper
• Evaluation of Anti-Angiogenic Therapy Combined with Immunotherapy and Chemotherapy as a Strategy to Treat Locally Advanced and Metastatic Non-Small-Cell Lung Cancer

  2024cites this paper
• Survival and relapse patterns in patients of cranial vs extra-cranial oligometastases treated with stereotactic radiosurgery/stereotactic body radiation therapy and systemic therapy

  2024cites this paper
• Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era

  2024cites this paper
• Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive Review

  2024cites this paper
• Convection-enhanced delivery of [177Lu]Lu-labeled gold nanoparticles combined with anti-PD1 checkpoint immunotherapy improves the survival of immunocompetent C57BL/6J mice with orthotopic GL261 murine glioma tumors.

  2024cites this paper
• Stereotactic Radiosurgery Dose Reduction for Melanoma Brain Metastases Patients on Immunotherapy or Target Therapy: A Single-Center Experience

  2024cites this paper
• The effects of immune checkpoint inhibitors vs. chemotherapy combined with brain radiotherapy in non-small cell lung cancer patients with brain metastases

  2024cites this paper
• Stereotactic radiosurgery for brain metastases from human epidermal receptor 2 positive breast Cancer: an international, multi-center study

  2024cites this paper
• [First-line immunotherapy in non-small cell lung cancer diagnosed with brain metastases].

  2024cites this paper
• Risk of late radiation necrosis more than 5 years after stereotactic radiosurgery.

  2024cites this paper
• Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060

  2024cites this paper
• The role of radiotherapy in immunotherapy strategies in the central nervous system.

  2024cites this paper
• Surgery of enlarging lesions after stereotactic radiosurgery for brain metastases in patients with non‐small cell lung cancer with oncogenic driver mutations frequently reveals radiation necrosis: case series and review

  2024influential citation
• Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape.

  2024cites this paper
• Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator‐based hypofractionated stereotactic radiosurgery for intact intracranial metastases

  2023cites this paper
• Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases

  2023cites this paper
• Effect of Immunotherapy and Stereotactic Body Radiation Therapy Sequencing on Local Control and Survival in Patients With Spine Metastases

  2023cites this paper
• Efficacy, Safety, and Health-Related Quality of Life with Camrelizumab Plus Pemetrexed and Carboplatin as First-Line treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer with Brain Metastases (CAP-BRAIN): A Multicentre, Open-Label, Single-Arm, Phase 2 Study.

  2023cites this paper
• The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastases

  2023cites this paper
• Efficacy of different therapies for brain metastases of non-small cell lung cancer: a systematic review and meta-analysis

  2023cites this paper
• SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases

  2023cites this paper
• Radiation necrosis or tumor progression? A review of the radiographic modalities used in the diagnosis of cerebral radiation necrosis

  2023influential citation
• The Impact of Immune Checkpoint Inhibition on the Risk of Radiation Necrosis Following Stereotactic Radiotherapy for Metastatic Brain Cancer

  2023cites this paper
• Whole brain radiation therapy resulting in radionecrosis: a possible link with radiosensitising chemoimmunotherapy

  2023cites this paper
• High Radiation Dose to the Fornix Causes Symptomatic Radiation Necrosis in Patients with Anaplastic Oligodendroglioma

  2023cites this paper
• Patterns of Failure Outcomes for Combination of Stereotactic Radiosurgery and Immunotherapy for Melanoma Brain Metastases

  2023cites this paper
• Hirnmetastasen

  2023cites this paper
• Presence of Activated (Phosphorylated) STAT3 in Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases

  2023cites this paper
• Factors Associated with Radiation Necrosis and Intracranial Control in Patients Treated with Immune Checkpoint Inhibitors and Stereotactic Radiotherapy.

  2023cites this paper
• The Safety and Efficacy of Concurrent Immune Checkpoint Blockade and Stereotactic Radiosurgery Therapy with Practitioner and Researcher Recommendations.

  2023cites this paper
• Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era

  2023cites this paper
• Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational Approaches

  2023cites this paper
• Stereotactic Radiosurgery Results in Non-Small-Cell Lung Cancer Patients with Brain Metastases in the Era of Modern Systemic Treatment Agents

  2023cites this paper
• Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases.

  2023cites this paper
• Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with brain metastases.

  2023cites this paper
• Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis

  2023cites this paper
• Neurotoxicity from Old and New Radiation Treatments for Brain Tumors

  2023cites this paper
• Regression of a melanoma brain metastasis that had appeared after immune checkpoint inhibitor discontinuation: a hypothesis-generating case

  2023cites this paper
• Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases

  2023cites this paper
• Cutaneous melanoma.

  2023cites this paper
• Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients

  2023cites this paper
• Hirnmetastasen

  2023cites this paper
• A Genomic Score to Predict Local Control among Patients with Brain Metastases Managed with Radiation.

  2023cites this paper
• Imaging-defined radionecrosis following stereotactic radiosurgery in the setting of immune checkpoint inhibitors - a cause for alarm or a harbinger of enhanced anti-tumor immunity?

  2023cites this paper
• Synergistic effects of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with lung cancer and brain metastases: a propensity score-matched analysis.

  2023cites this paper
• Radiation dose, schedule and novel systemic targets for radio-immunotherapy combinations.

  2023cites this paper
• Brain injury after cranial radiotherapy combined with immunotherapy for brain metastases in lung cancer: a retrospective study.

  2023cites this paper
• The abscopal effect: inducing immunogenicity in the treatment of brain metastases secondary to lung cancer and melanoma

  2023cites this paper
• Novel Mechanisms and Future Opportunities for the Management of Radiation Necrosis in Patients Treated for Brain Metastases in the Era of Immunotherapy

  2023influential citation
• Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis

  2023cites this paper
• Microglia promote anti-tumour immunity and suppress breast cancer brain metastasis

  2023cites this paper
• Efficacy of laser interstitial thermal therapy for biopsy-proven radiation necrosis in radiographically recurrent brain metastases

  2023cites this paper
• Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series

  2023influential citation
• Stereotactic Radiation Therapy for Brain Metastases: Factors Affecting Outcomes and Radiation Necrosis

  2023cites this paper
• Radionecrosis mimicking pseudo‑progression in a patient with lung cancer and brain metastasis following the combination of anti‑PD‑1 therapy and stereotactic radiosurgery: A case report

  2023cites this paper
• When Radiotherapy and Immunotherapy Dance-Who Leads So as Not to Step on Toes?

  2022cites this paper
• Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration Database.

  2022cites this paper
• Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy

  2022cites this paper
• Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization

  2022cites this paper